LOEP® included in 2019 IOF and ESCEO European guidance for the diagnosis and management of osteoporosis in postmenopausal women

Osteoporosis International recently published diagnosis and management guidance from ESCEO and IOF for postmenopausal women with osteoporosis.  The publication marks the first time that Local Osteo-Enhancement Procedure has been recognized in this global treatment guidance document. 

 

“Local osteo-enhancement procedure (LOEP) is a local treatment, which requires a minimally invasive injection in the femoral neck of a resorbable synthetic bone graft substitute, containing a proprietary triphasic calcium sulphate/calcium phosphate implant. . . . Femoral strength in sideway fall was 36% higher in treated than control femurs 5–7 years after the procedure. No safety issues were reported during the study (page 24).”

 

AgNovos Healthcare’s Chief Medical Officer and Company Founder, Dr. James Howe, commented “I am very pleased that the committees recognized the promise of LOEP to address local osteoporotic bone loss in patients at elevated risk of fracture, as evidenced by a wealth of pre-clinical and clinical data.  We continue to look forward to working tirelessly to make this treatment option available to as many clinicians and patients as soon as possible.”

For more information about the guidance document or LOEP, please refer to the link https://doi.org/10.1007/s00198-018-4704-5 and contact our medical affairs team [Here]

 


Archive

Category